Piedmont Heart Institute Napa Valley Cardiology Conference
Avatar

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

By Piedmont Heart Institute Napa Valley Cardiology Conference FEATURING Thomas Deering
November 15, 2019
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Houston Methodist DeBakey Heart and Vascular Center

11th Annual Multimodality Cardiovascular Imaging for the Clinician

Sat, Dec 11, 2021
25:21
Congenital and Structural Interventions

LAA Closure for Atrial Fibrillation using Occlusion Device

Feat. H. Sievert
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
19:47
Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Trip…

Feat. U. Baber
18:36
Texas Heart Institute

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

Feat. M. Razavi
16:37
Cardiopulmonary Research Science and Technology Institute

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation

Feat. G. Stone
12:55
Cardiology Fiesta 2018

Heart Failure and Atrial Fibrillation – What Is the Right Approach for You…

Feat. J. Pillarisetti
17:08
Jonathan Piccini

Which Direct Acting Oral Anticoagulant for my Patient with Chronic Kidney …

15:52
ARCH Advanced Revascularization Symposium

LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy

Feat. S. Yakubov
20:30
Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach

Transcatheter LAA Closure for Stroke Prevention: Current Data and Future D…

Feat. M. Price
30:04
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Outpatient Management of Atrial Fibrillation

Feat. N. Olson
19:28
Northwestern Medicine: 7th Annual Cardiovascular Update

Re-Visiting the Natural History of AF: Who is at Risk of Stroke and What a…

Feat. R. Passman
13:21
The North American Thrombosis Forum (NATF)

Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use…

Feat. C. Cruff
21:41
Cardiology Fiesta 2018

Results from the CABANA Trial: What Does it Mean

Feat. D. Packer
20:15
Cardiology Fiesta 2017

The Guidelines: Current Recommendations for TAVR, Left Atrial Appendage Oc…

Feat. S. Bailey
16:37
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Devices for Preventing Stroke in Patients with Atrial Fibrillation: How Di…

Feat. R. Reeves
14:25
California Heart Rhythm Symposium

Therapies for Atrial Fibrillation in the Next Decade

Feat. H. Calkins
19:58
George Davis

Anticoagulant Reversal Agents

19:11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Rationale and Practical Aspects for using NOAC’s to Treat Afib and VTE

Feat. D. Blanchard
13:43
American Heart & Vascular Institute

Review of Oral Anticoagulants for Atrial Fibrillation: What Are the Indica…

Feat. V. Le
32:34
Cardiovascular Disease Management: A Case-Based Approach 2018

Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Pra…

Feat. J. Bunch